{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:55:33Z","timestamp":1789847733744,"version":"4.0.1"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004495","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T19:05:08Z","timestamp":1457031908000},"page":"e0004495","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review"],"prefix":"10.1371","volume":"10","author":[{"given":"Johan","family":"van Griensven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalamaw","family":"Gadisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abate Mulugeta","family":"Beshah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"R Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"H Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"805108","DOI":"10.1155\/2013\/805108","article-title":"Mucosal leishmaniasis: an underestimated presentation of a neglected disease","volume":"2013","author":"A Strazzulla","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref5","unstructured":"(2011) Proceedings of the international consultative meeting on cutaneous leismaniasis in Ethiopia; Addis Ababa, July 4\u20135, 2011: Leish-mapping team at AHRI in collaboration with WHO-Ethiopia."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4081\/gh.2014.27","article-title":"Risk map for cutaneous leishmaniasis in Ethiopia based on environmental factors as revealed by geographical information systems and statistics","volume":"8","author":"A Seid","year":"2014","journal-title":"Geospat Health"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.trstmh.2009.02.023","article-title":"Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns","volume":"103","author":"V Padovese","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00034983.1969.11686649","article-title":"Studies on leishmaniasis in Ethiopia. I. Preliminary investigations into the epidemiology of cutaneous leishmaniasis in the highlands","volume":"63","author":"A Lemma","year":"1969","journal-title":"Ann Trop Med Parasitol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0035-9203(73)90088-6","article-title":"The epidemiology of cutaneous leishmaniasis in Ethiopia","volume":"67","author":"RW Ashford","year":"1973","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0035-9203(92)90546-O","article-title":"Cutaneous leishmaniasis in south-western Ethiopia: Ocholo revisited","volume":"86","author":"G Mengistu","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.trstmh.2008.03.021","article-title":"Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification","volume":"102","author":"E Negera","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-3156.2009.02336.x","article-title":"Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains","volume":"14","author":"F Pratlong","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e112410","DOI":"10.1371\/journal.pone.0112410","article-title":"NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines","volume":"9","author":"IC Caneda-Guzman","year":"2014","journal-title":"PLoS One"},{"key":"ref14","first-page":"CD005067","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"U Gonzalez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref16","unstructured":"Wells GS, B; O'Connell, D; Peterson, J; Welch, V; Losos, M; Tugwell, P (2011) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"key":"ref17","unstructured":"Higgens JG, S (2011) Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane collaboration."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.exppara.2013.01.022","article-title":"Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model","volume":"134","author":"M Utaile","year":"2013","journal-title":"Exp Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"P Escobar","year":"2002","journal-title":"Acta Trop"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0001-706X(92)90042-V","article-title":"An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1","volume":"51","author":"A Gebre-Hiwot","year":"1992","journal-title":"Acta Trop"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0035-9203(94)90106-6","article-title":"Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica","volume":"88","author":"S Teklemariam","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0037-86821996000500007","article-title":"Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis","volume":"29","author":"D Correia","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0035-9203(94)90235-6","article-title":"Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis","volume":"88","author":"J Soto","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(94)90237-2","article-title":"Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis","volume":"88","author":"NC Hepburn","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"M Mohebali","year":"2007","journal-title":"Acta Trop"},{"key":"ref26","first-page":"CD004834","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","author":"U Gonzalez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e2196","DOI":"10.1371\/journal.pntd.0002196","article-title":"Novel low-cost thermotherapy for cutaneous leishmaniasis in Peru","volume":"7","author":"BM Valencia","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref28","first-page":"110","article-title":"Pentamidine-induced diabetes mellitus","volume":"45","author":"A Bryceson","year":"1968","journal-title":"East Afr Med J"},{"key":"ref29","first-page":"170","article-title":"The cumulative effect of pentamidine dimethanesulphonate on the blood sugar","volume":"46","author":"A Bryceson","year":"1969","journal-title":"East Afr Med J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1371\/journal.pntd.0000225","article-title":"Pentamidine dosage: a base\/salt confusion","volume":"2","author":"TP Dorlo","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2133.2007.07872.x","article-title":"Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses","volume":"156","author":"O Zerpa","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0074-02762004000100010","article-title":"Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report","volume":"99","author":"J Convit","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/507708","article-title":"Immunotherapy for drug-refractory mucosal leishmaniasis","volume":"194","author":"R Badaro","year":"2006","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"MS Duthie","year":"2012","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1016\/j.vaccine.2010.08.092","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis","volume":"28","author":"A Llanos-Cuentas","year":"2010","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis","volume":"28","author":"E Nascimento","year":"2010","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.168.4.1659","article-title":"CpG oligodeoxynucleotides as vaccine adjuvants in primates","volume":"168","author":"D Verthelyi","year":"2002","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"C Bode","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1128\/AAC.00137-11","article-title":"CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis","volume":"55","author":"S Gupta","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.1000238","article-title":"Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis","volume":"185","author":"VS Raman","year":"2010","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.166.4.2372","article-title":"Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs","volume":"166","author":"D Verthelyi","year":"2001","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"P Olliaro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e1545","DOI":"10.1371\/journal.pntd.0001545","article-title":"More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects","volume":"6","author":"P Olliaro","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"M Balasegaram","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trstmh.2012.02.006","article-title":"Treatment response of cutaneous leishmaniasis due to Leishmania aethiopica to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia","volume":"106","author":"E Negera","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0035-9203(83)90213-4","article-title":"High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya","volume":"77","author":"JD Chulay","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0035-9203(95)90027-6","article-title":"Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to Leishmania aethiopica","volume":"89","author":"N Berhe","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0035-9203(78)90052-4","article-title":"Cutaneous leishmaniasis and leprosy","volume":"72","author":"RS Barnetson","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref50","first-page":"57","article-title":"Cutaneous leishmaniasis in Ethiopia","volume":"3","author":"EW Price","year":"1965","journal-title":"Ethiop Med J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0035-9203(78)90173-6","article-title":"A form of muco-cutaneous leishmaniasis in the Old World","volume":"72","author":"RS Barnetson","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref52","first-page":"7","article-title":"Cutaneous leishmaniasis cases seen in two years at the All Africa Leprosy and Rehabilitation Training Centre Hospital","volume":"22","author":"PA Sarojini","year":"1984","journal-title":"Ethiop Med J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1978.tb06181.x","article-title":"Failure of metronidazole treatment in Ethiopian mucocutaneous leishmaniasis","volume":"99","author":"A Belehu","year":"1978","journal-title":"Br J Dermatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0035-9203(69)90111-4","article-title":"Clinical trial of CI-501 (Camolar) against cutaneous leishmaniasis in Ethiopia","volume":"63","author":"A Bryceson","year":"1969","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4269\/ajtmh.1986.35.491","article-title":"Response to ketoconazole in two cases of longstanding cutaneous leishmaniasis","volume":"35","author":"J Viallet","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0190-9622(87)80033-6","article-title":"Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment","volume":"16","author":"L Weinrauch","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s15010-013-0500-5","article-title":"Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment","volume":"41","author":"V Mosimann","year":"2013","journal-title":"Infection"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4269\/ajtmh.2011.10-0712","article-title":"Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea","volume":"84","author":"P Zanger","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/00034983.1982.11687589","article-title":"Electron microscopical studies on cutaneous leishmaniasis in Ethiopia. I. The diffuse form and its treatment with pentamidine","volume":"76","author":"K Zaar","year":"1982","journal-title":"Ann Trop Med Parasitol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0035-9203(70)90173-2","article-title":"Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment","volume":"64","author":"AD Bryceson","year":"1970","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(82)92468-0","article-title":"Diabetes mellitus associated with pentamidine mesylate","volume":"1","author":"A Belehu","year":"1982","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0035-9203(85)90267-6","article-title":"Pentamidine-induced diabetes mellitus","volume":"79","author":"B Naafs","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(83)91769-5","article-title":"Treatment of diffuse cutaneous leishmaniasis with chlorpromazine ointment","volume":"1","author":"TH Henriksen","year":"1983","journal-title":"Lancet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/00015555-1338","article-title":"Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation?","volume":"93","author":"F Dassoni","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(81)90374-3","article-title":"Limited therapeutic action of rifampicin\/isoniazid against Leishmania aethiopica","volume":"2","author":"J van der Meulen","year":"1981","journal-title":"Lancet"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T19:49:07Z","timestamp":1539978547000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004495"}},"subtitle":[],"editor":[{"given":"Hechmi","family":"Louzir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004495","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,3]]}}}